Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Valacyclovir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CAN-2409 Improves Disease-Free Survival in Prostate Cancer
    CAN-2409 Improves Disease-Free Survival in Prostate Cancer

    02 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/02/3305133/0/en/candel-therapeutics-announces-publication-in-the-lancet-oncology-of-pivotal-phase-3-data-demonstrating-significant-improvement-in-disease-free-survival-with-aglatimagene-besadenove.html

    GLOBENEWSWIRE
    02 Jun 2026
    Share Share
    Manufacturing Issues Prompt FDA Rejection Of Hyloris Antiviral
    Manufacturing Issues Prompt FDA Rejection Of Hyloris Antiviral

    13 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-fires-another-manufacturing-related-crl-one-hyloris

    FIERCE PHARMA
    13 Mar 2026
    Share Share
    PridCor Therapeutics Reveals Successful Long COVID Case Series
    PridCor Therapeutics Reveals Successful Long COVID Case Series

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144735/0/en/PridCor-Therapeutics-Reports-Positive-Long-COVID-Case-Series-with-Combination-Antiviral-Regimen.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Virios Therapeutics Announces Second Quarter 2024 Financial Results
    Virios Therapeutics Announces Second Quarter 2024 Financial Results

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2927020/0/en/Virios-Therapeutics-Announces-Second-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Hyloris Announces Positive Clinical Study Results for Valacyclovir
    Hyloris Announces Positive Clinical Study Results for Valacyclovir

    26 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/12/26/2801123/0/en/Hyloris-Announces-Positive-Clinical-Study-Results-for-Valacyclovir-Oral-Suspension-HY-029.html

    GLOBENEWSWIRE
    26 Dec 2023
    Share Share
    GSK to cut US prices for Advair, Valtrex and Lamictal
    GSK to cut US prices for Advair, Valtrex and Lamictal

    23 Dec 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-cut-us-prices-advair-valtrex-lamictal-2023-12-22/

    REUTERS
    23 Dec 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.